Medical cannabis may help manage fibromyalgia, study finds
Medical cannabis may play a role in managing fibromyalgia and related symptoms of depression and anxiety, according to a peer-reviewed study published in the American Journal of Endocannabinoid Medicine. Three-fourths of the more than 800 patients assessed saw a significant decrease in their self-reported illness severity, according to the study, which was led by researchers at Harvest Medicine, a subsidiary of MediPharm Labs Corp. . Fibromyalgia is a chronic condition that affects about 4 million U.S. adults and causes musculoskeletal pain, fatigue and mood issues. Most patients in the study used CBD oil. Roughly half of the patients with severe anxiety or depression saw a reduction in those symptoms. MediPharm specializes in developing and manufacturing cannabis concentrates and active pharmaceutical ingredients. MediPharm stock was unchanged premarket on Thursday and has gained 15.6% in the year to date, while the S&P 500 has gained 17.6%.
-Eleanor Laise
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-31-23 0831ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth